Isomorphic Labs CEO Demis Hassabis at the Financial Times' Global Pharma and Biotech Summit (courtesy Financial Times)
Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025
Google’s bet on AI in drug discovery just got a lot bigger.
Isomorphic Labs said Monday it raised $600 million from Thrive Capital, GV and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
